Findings from a preclinical study led by VHIO’s Models of Cancer Therapies Group directed by Laura Soucek, an ICREA Research Professor and co-Founder and CSO of the VHIO and ICREA spin-off company ...
Burkitt's lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most ...
Unless otherwise listed, all solvents and reagents were purchased from Aldrich Chemical Co. (MO, USA) and used as received. Anhydrous chloroform and methanol were purchased from Aldrich Chemical Co.
Cambridge, MA, May 28 — Insilico Medicine (“Insilico”), in collaboration with research partner at Huadong Medicine Company, today announced the discovery of novel small-molecule inhibitors that ...
Please provide your email address to receive an email when new articles are posted on . Inhibiting RMB42 disrupted production of Myc proteins in pancreatic cancer cells. This approach could curtail ...
A new review in Genes and Diseases explores the central role of MYC, a master regulatory protein, in the development and progression of cancer, spotlighting its potential as a multidimensional ...
Researchers at CSH Laboratory identified an oncogenic SRSF1–AURKA–MYC circuit driving pancreatic ductal adenocarcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback